{"id":"W3134178812","doi":"10.1200/jco.2021.39.6_suppl.270","title":"Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Sunitinib; Cabozantinib; Internal medicine; Crizotinib; Renal cell carcinoma; Oncology; Pazopanib; Progression-free survival; Urology; Surgery; Chemotherapy; Lung cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003277145,0.00126232,0.002182818,0.0004279842,0.0002538822,0.0007622943,0.0007936308,0.001090878,0.004361233],"category_scores_gemma":[0.001899546,0.0005117247,0.001876991,0.0004237557,0.0008352232,0.0008344742,0.0002793374,0.001915248,0.0006690182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001255485,"about_ca_system_score_gemma":0.00137638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001386198,"about_ca_topic_score_gemma":0.004529934,"domain_scores_codex":[0.9991757,0.0005153515,0.00005847252,0.0001011885,0.00005804371,0.00009121244],"domain_scores_gemma":[0.9989161,0.0003457734,0.0003099892,0.00006381634,0.0000501535,0.0003141816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9581234,0.006883257,0.002162894,0.0006168521,0.001128759,0.00004278389,0.00006351381,0.0006008933,0.003650781,0.0001054941,0.001060192,0.02556113],"study_design_scores_gemma":[0.8619863,0.1286815,0.006004293,0.00004221958,0.0009175724,0.00007721887,0.00002800344,0.0006356742,0.000626569,0.0001491122,0.0008362652,0.0000151885],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900442,0.004356179,0.0005079373,0.0004652049,0.0002002641,0.001827798,0.001138963,0.00007333767,0.001386104],"genre_scores_gemma":[0.9917294,0.002139464,0.000967515,0.0006842322,0.0001985776,0.001364415,0.001332536,0.00001987882,0.001563832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004361233,"threshold_uncertainty_score":0.01733136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2216947371488914,"score_gpt":0.4630707397537619,"score_spread":0.2413760026048705,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}